FUT10 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 6.43219999485467E-09 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.68504999999985E-05 |
Normal-vs-Stage2 |
6.485000E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
8.021400E-03 |
Stage1-vs-Stage2 |
2.603600E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
6.352800E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
6.250800E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.87789999994692E-07 |
Normal-vs-AfricanAmerican |
1.947610E-01 |
Normal-vs-Asian |
7.746000E-02 |
Caucasian-vs-AfricanAmerican |
5.878400E-02 |
Caucasian-vs-Asian |
2.185800E-01 |
AfricanAmerican-vs-Asian |
5.352800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.805860E-04 |
Normal-vs-Female |
3.23639999999514E-06 |
Male-vs-Female |
1.770430E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.052080E-02 |
Normal-vs-Extreme_Weight |
1.52721999999716E-05 |
Normal-vs-Obese |
1.834310E-02 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
9.770800E-01 |
Normal_Weight-vs-Obese |
5.695800E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
5.187800E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.482000E-01 |
Normal-vs-Age(41-60Yrs) |
6.363000E-04 |
Normal-vs-Age(61-80Yrs) |
2.0509999999474E-06 |
Normal-vs-Age(81-100Yrs) |
5.515200E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.038300E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.300900E-03 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.134200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.702600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.945600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.052600E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
2.050000E-01 |
Normal-vs-Grade 3 |
2.910800E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
6.023800E-01 |
Grade 2-vs-Grade 4 |
2.050000E-01 |
Grade 3-vs-Grade 4 |
2.910800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.24419999994563E-06 |
Normal-vs-N1 |
1.010110E-02 |
N0-vs-N1 |
4.102200E-01 |
|
|